Rockefeller Capital Management
PALI icon

Rockefeller Capital Management’s Palisade Bio PALI Stock Holding History

Rockefeller Capital Management’s Portfolio PALI Stock Details PALI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$875 Hold
500
– – ﹤0.01% 4503
2025
Q4 		$1.18K Hold
500
– – ﹤0.01% 4429
2025
Q3 		$430 Buy
+500
New +$391 ﹤0.01% 4286

Other funds holding PALI

Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
BGI
B Group Inc Dallas, Texas $135M AUM 80% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

Rockefeller Capital Management's PALI Position: Q1 2026 in Review

Rockefeller Capital Management held its Palisade Bio (PALI) position steady in Q1 2026 at 500 shares worth $875. The position accounts for ﹤0.01% of the portfolio, ranked #4503.

Rockefeller Capital Management first reported a position in PALI in Q3 2025 and has held it in 3 quarters since. The position peaked at $1.18K in Q4 2025. 96 funds tracked by Wall St. Rank hold PALI as of Q1 2026.

  • Rockefeller Capital Management held 500 shares of Palisade Bio worth $875 as of Q1 2026.
  • Rockefeller Capital Management left its Palisade Bio share count unchanged in Q1 2026.
  • Palisade Bio made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q1 2026, its #4503 holding.
  • Rockefeller Capital Management first reported a position in Palisade Bio in Q3 2025 and has held it in 3 quarters since.
  • Rockefeller Capital Management's Palisade Bio position peaked at $1.18K in Q4 2025.
  • 96 funds tracked by Wall St. Rank held Palisade Bio as of Q1 2026.

Based on Rockefeller Capital Management's 13F filing for Q1 2026, filed 14 May 2026.